An investigation by the S.E.C. and several states found that the company had failed to notify investors of changes in the terms of some funds, leading to higher capital gains taxes.
Category: Securities and Exchange Commission
-
Robinhood to Pay $45 Million Fine to Settle SEC Charges
The upstart brokerage agreed to pay the Securities and Exchange Commission for failing to protect sensitive customer data, among other infractions.
-
Vince McMahon Settles With S.E.C. Over Failing to Disclose Confidential Payments to Women
The former chief executive of World Wrestling Entertainment paid two women, one of whom accused him of assault.
-
Elon Musk and DOGE vs. Regulators
The billionaire has needled government agencies, armed with potential influence over their budgets. But some of these organizations are also looking into his interests.
-
Eric Trump Promises the ‘Most Pro-Crypto President’ in History
Speaking at a Middle East conference, President-elect Donald J. Trump’s son said his family had embraced cryptocurrency because some banks stopped doing business with them after Jan. 6.
-
Bitcoin Price Surges to a Milestone: $100,000
The price of a single Bitcoin rose to six figures for the first time, an extraordinary level for a 16-year-old cryptocurrency once dismissed as a sideshow.
-
Trump Picks Paul Atkins to Run the S.E.C.
Mr. Atkins, a pro-business conservative, would likely take a lighter regulatory approach than the current chair of the Securities and Exchange Commission.
-
Crypto Industry Lobbies Trump and His Allies After Election Wins
As Bitcoin soars to record highs, cryptocurrency executives are maneuvering to influence Donald J. Trump’s transition and secure their policy goals.
-
The Crypto Industry’s Spending on the Election Pays Off
The spending spree fueled a string of victories on Tuesday for congressional candidates who had expressed support for cryptocurrencies.
-
Victims of Stanford Financial’s Fraud Scheme May Soon Be Paid. Some Already Sold Their Claim.
Not having much insight into what may happen next in the case of a fraud orchestrated by Robert Allen Stanford, many of the victims sold the rights to any future payout.
-
Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.